Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain

Virology

Volumn 355, Issue 2, 2006, Pages 192-202

  Lanford, Robert E ^a   Guerra, Bernadette ^a   Lee, Helen ^a  

^a SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

HCV; IFN ; Interferon stimulated genes; ISG

Indexed keywords

ALPHA INTERFERON; NONSTRUCTURAL PROTEIN 5A; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHIMERA; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; REPLICON; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CELL LINE; GENOTYPE; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RECOMBINATION, GENETIC; REPLICON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3;

EID: 33750616050     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.07.019     Document Type: Article

References (61)

1. Alter H.J., and Seeff L.B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 20 (2005) 17-35
2. Appel N., Pietschmann T., and Bartenschlager R. Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J. Virol. 79 (2005) 3187-3194
3. Bigger C.B., Guerra B., Brasky K.M., Hubbard G., Beard M.R., Luxon B.A., Lemon S.M., and Lanford R.E. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J. Virol. 78 (2004) 13779-13792
4. Blight K.J., Kolykhalov A.A., and Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290 (2000) 1972-1974
5. Blight K.J., McKeating J.A., and Rice C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76 (2002) 13001-13014
6. Blight K.J., McKeating J.A., Marcotrigiano J., and Rice C.M. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J. Virol. 77 (2003) 3181-3190
7. Castelain S., Khorsi H., Roussel J., Francois C., Jaillon O., Capron D., Penin F., Wychowski C., Meurs E., and Duverlie G. Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity. J. Infect. Dis. 185 (2002) 573-583
8. Cheney I.W., Lai V.C.H., Zhong W.D., Brodhag T., Dempsey S., Lim C., Hong Z., Lau J.Y.N., and Tam R.C. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J. Virol. 76 (2002) 11148-11154
9. El Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 (2004) S27-S34
10. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., and Izumi N. Interferon sensitivity determining sequence of the hepatitis C virus genome. Hepatology 24 (1996) 460-461
11. Evans M.J., Rice C.M., and Goff S.P. Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13038-13043
12. Feld J., and Hoofnagle J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436 (2005) 967-972
13. Fiedler M., Rodicker F., Salucci V., Lu M.J., Aurisicchio L., Dahmen U., Jun L., Dirsch O., Putzer B.M., Palombo F., and Roggendorf M. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo. J. Virol. 78 (2004) 10111-10121
14. Foy E., Li K., Wang C.F., Sumpter R., Ikeda M., Lemon S.M., and Gale M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145-1148
15. Foy E., Li K., Sumpter R., Loo Y.M., Johnson C.L., Wang C.F., Fish P.M., Yoneyama M., Fujita T., Lemon S.M., and Gale M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2986-2991
16. Frese M., Pietschmann T., Moradpour D., Haller O., and Bartenschlager R. Interferon-a inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J. Gen. Virol. 82 (2001) 723-733
17. Frese M., Schwarzle V., Barth K., Krieger N., Lohmann V., Mihm S., Haller O., and Bartenschlager R. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35 (2002) 694-703
18. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 975-982
19. Gale Jr. M., and Foy E.M. Evasion of intracellular host defence by hepatitis C virus. Nature 436 (2005) 939-945
20. Gale M.J., Korth M.J., Tang N.M., Tan S.L., Hopkins D.A., Dever T.E., Polyak S.J., Gretch D.R., and Katze M.G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230 (1997) 217-227
21. Gale M., Blakely C.M., Kwieciszewski B., Tan S.L., Dossett M., Tang N.M., Korth M.J., Polyak S.J., Gretch D.R., and Katze M.G. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18 (1998) 5208-5218
22. Geiss G.K., Carter V.S., He Y., Kwieciszewski B.K., Holzman T., Korth M.J., Lazaro C.A., Fausto N., Bumgarner R.E., and Katze M.G. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J. Virol. 77 (2003) 6367-6375
23. Girard S., Shalhoub P., Lescure P., Sabile A., Misek D.E., Hanash S., Brechot C., and Beretta L. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295 (2002) 272-283
24. Gochee P.A., Jonsson J.R., Clouston A.D., Pandeya N., Purdie D.M., and Powell E.E. Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1. J. Gastroenterol. Hepatol. 18 (2003) 386-392
25. Gu B.H., Gates A.T., Isken O., Behrens S.E., and Sarisky R.T. Replication studies using genotype 1a subgenomic hepatitis C virus replicons. J. Virol. 77 (2003) 5352-5359
26. Guo J.T., Bichko V., and Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75 (2001) 8516-8523
27. Helbig K.J., Ruszkiewicz A., Semendirc K., Harley H.A.J., McColl S.R., and Beard M.R. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 39 (2004) 1220-1229
28. Honda M., Beard M.R., Ping L.H., and Lemon S.M. A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J. Virol. 73 (1999) 1165-1174
29. Ikeda M., Yi M.K., Li K., and Lemon S.A. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76 (2002) 2997-3006
30. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., and Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005) 981-988
31. Kim W.R., Gores G.J., Benson J.T., Therneau T.M., and Melton III L.J. Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology 129 (2005) 486-493
32. Kumar D., Farrell G.C., Fung C., and George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response. Hepatology 36 (2002) 1266-1272
33. Lanford R.E., Lee H., Chavez D., Guerra B., and Brasky K.M. Infectious cDNA clone of the hepatitis C virus genotype 1 prototype sequence. J. Gen. Virol. 82 (2001) 1291-1297
34. Lanford R.E., Guerra B., Lee H., Averett D.R., Pfeiffer B., Chavez D., Notvall L., and Bigger C. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(I)-poly(C), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J. Virol. 77 (2003) 1092-1104
35. Lanford R.E., Guerra B., Lee H., Chavez D., Brasky K., and Bigger C.B. Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology 43 (2006) 961-972
36. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C.M., Ikeda M., Ray S.C., Gale M., and Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2992-2997
37. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
38. Lindenbach B.D., Meuleman P., Ploss A., Vanwolleghem T., Syder A.J., McKeating J.A., Lanford R.E., Feinstone S.M., Major M.E., Leroux-Roels G., and Rice C.M. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. 103 (2006) 3805-3809
39. Lohmann V., Körner F., Koch J.O., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
40. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Ling M.H., and Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
41. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIGI antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
42. Monto A., Alonzo J., Watson J.J., Grunfeld C., and Wright T.L. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 36 (2002) 729-736
43. Moradpour D., Evans M.J., Gosert R., Yuan Z., Blum H.E., Goff S.P., Lindenbach B.D., and Rice C.M. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 78 (2004) 7400-7409
44. Neddermann P., Quintavalle M., Di Pietro C., Clementi A., Cerretani M., Altamura S., Bartholomew L., and De Francesco R. Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture. J. Virol. 78 (2004) 13306-13314
45. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., and Bartenschlager R. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 76 (2002) 4008-4021
46. Podevin P., Sabile A., Gajardo R., Delhem N., Abadie A., Lozach P.Y., Beretta L., and Brechot C. Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR independent manner. Hepatology 33 (2001) 1503-1511
47. Polyak S.J., Khabar K.S.A., Paschal D.M., Ezelle H.J., Duverlie G., Barber G.N., Levy D.E., Mukaida N., and Gretch D.R. Hepatitis C virus nonstructural 5A protein induces interleukin8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75 (2001) 6095-6106
48. Poynard T., McHutchison J., Manns M., and Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 38 (2003) 481-492
49. Seth R.B., Sun L., Ea C.K., and Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kB and IRF3. Cell 122 (2005) 669-682
50. Tan S.L., and Katze M.G. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 284 (2001) 1-12
51. Tan S.L., Nakao H., He Y., Vijaysri S., Neddermann P., Jacobs B.L., Mayer B.J., and Katze M.G. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5533-5538
52. Tellinghuisen T.L., Marcotrigiano J., Gorbalenya A.E., and Rice C.M. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J. Biol. Chem. 279 (2004) 48576-48587
53. Thomas D., and Seeff L.B. Natural history of hepatitis C. Clin. Liver Dis. 9 (2005) 383-398
54. Tu H., Gao L., Shi S.T., Taylor D.R., Yang T., Mircheff A.K., Wen Y.M., Gorbalenya A.E., Hwang S.B., and Lai M.M. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 263 (1999) 30-41
55. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
56. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., and Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19 (2005) 727-740
57. Yi M., and Lemon S.M. Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J. Virol. 78 (2004) 7904-7915
58. Yi M., Villanueva R.A., Thomas D.L., Wakita T., and Lemon S.M. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad. Sci. 103 (2006) 2310-2315
59. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 699-701
60. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. 102 (2005) 9294-9299
61. Zhu Q., Guo J.T., and Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J. Virol. 77 (2003) 9204-9210